In the realm of American style health care, operations are revenue generating and are rarely cancelled, in our Canadian system operations are costs that need to be contained.
I am grateful that Pace benefits from the universality of Canadian Health Care. It cost $8,000.00 per treatment of Abraxane and $920.00 per treatment of FEC, totaling $99,680.00 for Pace's chemotherapy drugs alone.
How product managers at any oncological pharmaceutical companies expect the middle class to keep up with these kind of bills is beyond me.
Wednesday, August 02, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment